Sinontx

1 known investors

SiNON Nano Sciences develops a carbon nanoparticle (CNP) platform for targeted drug delivery across the blood-brain barrier, enabling non-invasive, sustained release of therapies for severe neurological conditions. It partners with drug developers to formulate nanoparticle-encapsulated biologics and therapeutic agents, including repositioning drugs limited by toxicity or poor brain delivery.